SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,608,000 | +22.3% | 151,900 | -7.4% | 0.25% | +1.2% |
| Q1 2020 | $2,950,000 | +1353.2% | 164,000 | +2423.1% | 0.24% | +542.1% |
| Q1 2017 | $203,000 | -24.5% | 6,500 | -39.1% | 0.04% | -37.7% |
| Q4 2016 | $269,000 | +26.9% | 10,671 | +24.7% | 0.06% | +32.6% |
| Q3 2016 | $212,000 | +4.4% | 8,557 | -35.8% | 0.05% | -41.0% |
| Q1 2016 | $203,000 | +4.1% | 13,334 | -4.2% | 0.08% | -16.1% |
| Q3 2015 | $195,000 | – | 13,913 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |